Analyze Diet

Topic:Pharmacodynamics

Pharmacodynamics in horses refers to the study of how drugs affect the equine body, encompassing the mechanisms of action, the relationship between drug concentration and effect, and the duration of these effects. This field examines how drugs interact with biological systems in horses to produce therapeutic or adverse effects. Key aspects include receptor binding, post-receptor effects, and chemical interactions. Understanding pharmacodynamics is essential for determining appropriate dosages, predicting drug interactions, and assessing therapeutic outcomes in equine medicine. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacodynamic properties of various drugs in horses, focusing on their effects, efficacy, and safety profiles.
[The clinical pharmacology of glycerol guaiacolate ether in the horse–a review].
Journal of the South African Veterinary Association    December 1, 1986   Volume 57, Issue 4 247-249 
Stadler P.The physical and chemical properties, administration, biotransformation, pharmacological effects, clinical applications, side-effects, toxicity and contraindications of glyceryl guaiacolate ether in the horse are reviewed.
Pharmacokinetics of rifampin given as a single oral dose in foals.
American journal of veterinary research    December 1, 1986   Volume 47, Issue 12 2584-2586 
Castro LA, Brown MP, Gronwall R, Houston AE, Miles N.Six foals from 6 to 8 weeks of age were given a single oral dose of rifampin at a dosage of 10 mg/kg of body weight. Serum rifampin concentrations were measured serially during a 24-hour period. The mean peak serum rifampin concentration was 6.7 micrograms/ml at 4 hours after treatment. The concentration decreased slowly, and at 24 hours the mean value was 2.7 micrograms/ml. The elimination half-life was 17.5 hours, and the elimination rate constant was 0.04/hr.
Pharmacokinetics and endometrial tissue concentrations of ticarcillin given to the horse by intravenous and intrauterine routes.
American journal of veterinary research    December 1, 1986   Volume 47, Issue 12 2587-2590 
Spensley MS, Baggot JD, Wilson WD, Hietala SK, Mihalyi JE.Plasma and endometrial tissue concentrations of ticarcillin were measured in healthy mares. In the first of the 3 separate phases comprising the study, ticarcillin disodium (30 mg/kg) was administered IV. The mean peak concentration in endometrial tissue, 12.9 micrograms/g, was attained at 30 minutes. The plasma half-life of the drug in the 6 mares was 0.83 +/- 0.22 hour. Six grams of the drug was diluted in 250 ml of sodium chloride injection USP (2nd phase) and in 60 ml of sodium chloride injection USP (3rd phase). These dilutions were administered by intrauterine infusion. In phase 2, the m...
Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation.
American journal of veterinary research    November 1, 1986   Volume 47, Issue 11 2359-2363 
Lees P, Higgins AJ.In a 12-day treatment schedule, 5 ponies were given orally a paste formulation of phenylbutazone (PBZ) and 5 matched ponies were given equivalent doses of a placebo paste. On day 12, a mild, nonimmune inflammatory reaction was induced subcutaneously in the neck of each pony by inserting sterile, polyester sponge strips soaked in a 2% carrageenan solution. Exudate was collected at 4, 8, 12, and 24 hours by serial removal of sponges. There were no significant (P less than 0.05) differences in exudate protein concentration and leukocyte numbers between the treatment groups, but the group given PB...
High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples.
Analytical chemistry    October 1, 1986   Volume 58, Issue 12 2453-2460 doi: 10.1021/ac00125a022
Covey TR, Lee ED, Henion JD.No abstract available
Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
American journal of veterinary research    October 1, 1986   Volume 47, Issue 10 2309-2312 
Byars TD, Greene CE, Kemp DT.Warfarin-induced anticoagulation and reversal of the induced anticoagulation by vitamin K1 were evaluated in 4 mature horses. Each horse was given warfarin IV until the prothrombin (PT) time was prolonged by approximately 1.5 times the predosing base-line value. In experiment 1, we evaluated the time required for PT to return to the predosing value (PT reversal time) after warfarin administration was discontinued. Between each experiment, a 1-week rest period was allowed. In experiment 2, two doses of vitamin K1 (100 mg/dose) were administered IM 6 hours apart, and the PT was monitored hourly ...
Cardiovascular and pharmacokinetic effects of isoxsuprine in the horse.
American journal of veterinary research    October 1, 1986   Volume 47, Issue 10 2130-2133 
Matthews NS, Gleed RD, Short CE, Burrows K.Isoxsuprine (0.6 mg/kg) administered IV to 6 standing horses produced substantial, transient decreases in systemic blood pressure, systemic vascular resistance, and stroke volume. It also produced substantial, transient increases in heart rate, cardiac output, and purposeful movement. Plasma concentrations of isoxsuprine peaked soon after the drug was administered IV and then decreased over a 12-hour period in a biexponential manner, with distribution and elimination half-lives of 14 minutes and 2.67 hours, respectively. Total body clearance and steady-state volume of distribution were calcula...
Pharmacokinetics and diuretic effect of bumetanide following intravenous and intramuscular administration to horses.
Journal of veterinary pharmacology and therapeutics    September 1, 1986   Volume 9, Issue 3 310-317 doi: 10.1111/j.1365-2885.1986.tb00046.x
Delbeke FT, Debackere M, Desmet N, Stevens M.Concentrations of the potent diuretic bumetanide were determined by a sensitive high performance liquid chromatographic procedure in plasma and urine from horses following intravenous and intramuscular administration of a dose rate of 15 micrograms/kg. The elimination half-life was found to be 6.3 min, the volume of distribution at steady state 68 ml/kg and the total plasma clearance 10.9 ml/min/kg. The onset of diuresis occurred within 15 min and diuresis was no longer apparent 1 h after i.v. administration. Given by the intramuscular (i.m.) route, bumetanide was rapidly absorbed; bioavailabi...
Absorption of phenylbutazone from a paste formulation administered orally to the horse.
Research in veterinary science    September 1, 1986   Volume 41, Issue 2 200-206 
Lees P, Higgins AJ, Mawhinney IC, Reid DS.The absorption pattern of phenylbutazone was studied in five horses during administration of the drug in a paste formulation on days 1, 5, 8 and 12 of a 12-day dosing schedule. Since two or more plasma concentration peaks were usually obtained following each oral dose, it was concluded that phasic absorption was a particular feature of the oil:water formulation of the product. Possible causes of this unusual absorption pattern are discussed and the therapeutic implications of both phasic absorption and the recorded values of Cmax, tmax and AUC024 for phenylbutazone and its active metabolite ox...
How drugs act in the body.
The Veterinary record    August 9, 1986   Volume 119, Issue 6 132-135 doi: 10.1136/vr.119.6.132
Marriner SE.No abstract available
Pharmacokinetics of metronidazole given to horses by intravenous and oral routes.
American journal of veterinary research    August 1, 1986   Volume 47, Issue 8 1726-1729 
Sweeney RW, Sweeney CR, Soma LR, Woodward CB, Charlton CA.Serum and peritoneal fluid concentrations of metronidazole were determined in 6 healthy adult horses given the drug (25 mg/kg) by IV or oral routes. The disposition of metronidazole in horses given the drug by the IV route conformed to a 2-compartment model with a distribution half-life of 0.16 hours, an elimination half-life of 2.9 hours, and a body clearance of 0.40 +/- 0.05 L/kg/hr. The oral absorption half-life was 0.40 hours, and the bioavailability, 85.0 +/- 18.6%. Peritoneal fluid concentrations were approximately equal to serum concentrations at all times, regardless of the route of ad...
Prediction of pharmacokinetic profiles of ampicillin sodium, gentamicin sulfate, and combination ampicillin sodium-gentamicin sulfate in serum and synovia of healthy horses.
American journal of veterinary research    July 1, 1986   Volume 47, Issue 7 1590-1596 
Bowman KF, Dix LP, Riond JL, Riviere JE.Pharmacokinetics of ampicillin sodium (11 mg/kg), gentamicin sulfate (2.2 mg/kg), and combination ampicillin sodium-gentamicin sulfate were determined for serum and synovia of healthy horses given single-dose IV injection and were not found to be different from those from other reports; however, a prolonged terminal gamma-phase for gentamicin (8,498 +/- 1,842 minutes) in serum of horses was found to exist. Pharmacokinetic interaction between combination ampicillin sodium-gentamicin sulfate was not observed int he serum or synovia. Prediction of ampicillin sodium or gentamicin sulfate concentra...
Dobutamine-induced augmentation of cardiac output does not enhance respiratory gas exchange in anesthetized recumbent healthy horses.
American journal of veterinary research    July 1, 1986   Volume 47, Issue 7 1573-1576 
Swanson CR, Muir WW.The influence of pharmacologic enhancement of cardiac output on the alveolar-to-arterial oxygen tension (difference (P[A-a]O2), physiologic right-to-left shunt fraction (Qs/Qt), and physiologic dead space-to-tidal volume ratio (VD/VT) ws studied in halothane-anesthetized horses in left lateral, right lateral, and dorsal recumbencies. Adult horses were anesthetized, using xylazine (2.2 mg/kg, IM), guaifenesin (50 mg/kg, IV), thiamylal (4.4 mg/kg, IV), and halothane (1.5% to 2% inspired) in 100% O2. Mechanical ventilation was controlled to maintain arterial eucapnia (PaCO2) 35 to 45 mm of Hg) fo...
Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methylprednisolone acetate.
Equine veterinary journal    May 1, 1986   Volume 18, Issue 3 193-198 doi: 10.1111/j.2042-3306.1986.tb03594.x
Autefage A, Alvinerie M, Toutain PL.Synovial fluid and plasma kinetics of methylprednisolone acetate (MPA) and methylprednisolone (MP) after a single intra-articular administration of MPA at a therapeutic dose (111 mg in toto) was measured in five horses. MPA was detected in synovial fluid for two to six days post injection and MP, which results from synovial MPA hydrolysis, was present in pharmacologically significant concentrations for 4.8 to 39 days, depending on the horse. MPA synovial concentration was maximal (289 +/- 284 micrograms/ml) at the first sampling time (2 h after administration) and MP synovial concentration was...
Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
Research in veterinary science    March 1, 1986   Volume 40, Issue 2 152-156 
Hardee MM, Moore JN, Hardee GE.The efficacy of three agents which alter the metabolism of arachidonic acid was investigated in normal, conscious horses. A dose response evaluation was made of flunixin meglumine and phenylbutazone, two cyclo-oxygenase inhibitors, and of a selective thromboxane synthetase inhibitor, UK-38,485. Radioimmunoassay of thromboxane B2 (TxB2) and 6-keto prostaglandin F1 alpha (PGF1 alpha) was used to assess the concentrations of thromboxane A2 (TxA2) and prostacyclin (PGI2) respectively, in serum. Flunixin was the most potent inhibitor of serum TxB2 and 6-keto PGF1 alpha production. UK-38,485 also de...
Phenylbutazone in the horse: a review.
Journal of veterinary pharmacology and therapeutics    March 1, 1986   Volume 9, Issue 1 1-25 doi: 10.1111/j.1365-2885.1986.tb00008.x
Tobin T, Chay S, Kamerling S, Woods WE, Weckman TJ, Blake JW, Lees P.Phenylbutazone is an acidic, lipophilic, non-steroidal anti-inflammatory drug (NSAID). It is extensively metabolized in the horse. The metabolites so far identified, oxyphenbutazone, gamma-hydroxyoxyphenbutazone, account for some 25-30% of administered dose over 24 h. The plasma half-life of phenylbutazone and termination of its pharmacological action are determined primarily by its rate of hepatic metabolism. Phenylbutazone acts by inhibiting the cyclooxygenase enzyme system, which is responsible for synthesis of prostanoids such as PGE2. It appears to act on prostaglandin-H synthase and pros...
Gentamicin dosage in foals aged one month and three months.
Equine veterinary journal    March 1, 1986   Volume 18, Issue 2 113-116 doi: 10.1111/j.2042-3306.1986.tb03560.x
Baggot JD, Love DN, Stewart J, Raus J.The absorption and disposition kinetics of gentamicin were compared at two dosage levels (2 and 4 mg/kg bodyweight [bwt]) in one- and three-month-old foals. Following intramuscular (im) injection of single 2 mg/kg bwt doses, the drug was absorbed rapidly and produced peak serum concentration (18.2 mu 5.3 +/- g/ml, n = 8) at 30 mins. Much wider variations were associated with the amount of drug absorbed and the serum gentamicin concentrations after administration at the higher dosage level. The half-life of gentamicin was similar in the one-month-old (3.7 +/- 1.7 h, n = 8) and three-month-old (...
Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies.
Journal of veterinary pharmacology and therapeutics    March 1, 1986   Volume 9, Issue 1 26-39 doi: 10.1111/j.1365-2885.1986.tb00009.x
Maitho TE, Lees P, Taylor JB.The disposition of phenylbutazone (4.4 mg/kg), administered intravenously to six Welsh Mountain ponies, was described by a two-compartment open model. Pharmacokinetic parameters were not significantly different after morning dosing in comparison with afternoon dosing. When phenylbutazone (4.4 mg/kg) was administered orally to the same ponies, marked variations in time to peak concentrations were produced with different feeding schedules. When access to hay was permitted before and after dosing, the mean time to peak concentration was 13.2 +/- 1.2 h and double peaks in the plasma concentration-...
Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
American journal of veterinary research    February 1, 1986   Volume 47, Issue 2 453-454 
Brown MP, Gronwall RR, Martinez DS, Beal C.Six healthy pony foals, from 2 to 11 days of age, were given a single IM injection of amikacin sulfate (250 mg/ml) at a dosage rate of 7 mg/kg of body weight. Serum amikacin concentrations were measured serially over a 24-hour period. The mean peak serum concentration was 14.7 micrograms/ml at 0.5 hour. The elimination rate constant for amikacin was 0.24/hour, the elimination half-life was 3.0 hours, and the apparent volume of distribution was 0.58 L/kg.
Cardiovascular and pulmonary function studies of a new sedative/analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 139-155 
Short CE, Matthews N, Harvey R, Tyner CL.No abstract available
Detomidine/ketamine anaesthesia in the horse.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 167-179 
Clarke KW, Taylor PM, Watkins SB.No abstract available
Novel environment suppression of stallion sexual behavior and effects of diazepam.
Physiology & behavior    January 1, 1986   Volume 37, Issue 3 503-505 doi: 10.1016/0031-9384(86)90214-3
McDonnell SM, Kenney RM, Meckley PE, Garcia MC.Pony stallions were given sexual behavior trials in experimental "home" and "novel" environments, similar in all major features except location. In the novel environment, erection latency was increased and erection time decreased. Treatment with an anxiolytic benzodiazepine derivative (diazepam) appeared to block these effects.
Sedative and analgesic effects of detomidine in horses and cattle. Based on a symposium. Turku, Finland, September 2-4, 1985.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 1-206 
No abstract available
Sedative and analgesic action of detomidine in horses as evaluated from evoked potentials.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 97-109 
Stenberg D, Sandström M, Pyyhtiä AM, Kuussaari J.No abstract available
Sedation and analgesia with Domosedan (detomidine hydrochloride) in horses: dose response studies on efficacy and its duration.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 69-84 
Jöchle W, Hamm D.No abstract available
Analgesic and sedative effects of detomidine compared to xylazine in a colic model using i.v. and i.m. routes of administration.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 85-95 
Lowe JE, Hilfiger J.No abstract available
Cardiac effects of atropine premedication in horses sedated with detomidine.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 131-136 
Alitalo I, Vainio O, Kaartinen L, Raekallio M.No abstract available
The effect of sedatives on lung function in horses.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 111-120 
Reitemeyer H, Klein HJ, Deegen E.No abstract available
Preliminary report on the cardiorespiratory effects of the antagonist to detomidine, MPV-1248.
Acta veterinaria Scandinavica. Supplementum    January 1, 1986   Volume 82 121-129 
Nilsfors L, Kvart C.No abstract available
Detomidine in horses.
The Veterinary record    December 21, 1985   Volume 117, Issue 25-26 674-675 doi: 10.1136/vr.117.25-26.674
Clarke KW, Taylor PM.No abstract available
1 31 32 33 34 35 39